ArticleMetabolic brain disease2025
A novel modulator of the Axin/β-Catenin interaction to restore EAAT2 expression in alzheimer's disease: an in-silico and in-vitro approach.
Harminder Kaur et al.PubMed ↗Publisher ↗
No numbers read from the abstract.